ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer
The ERBB2 I655V mutation may be associated with improved treatment response to immunotherapy in gallbladder cancer.
Authors
- Kang-shuai Li
- Yunghun You (ORCID: https://orcid.org/0000-0002-0684-7523)
- Zong-li Zhang
- Qiang Gao
- Shuo Lian
- Chang Pan
Institutions
- Shandong University (CN)
- Shandong Provincial Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1186/s12957-026-04227-4
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shandong University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province